BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34791403)

  • 1. Interstitial lung disease in a woman with rheumatoid arthritis treated with denosumab: A case report.
    Mori Y; Izumiyama T; Mori N; Aizawa T
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):155-159. PubMed ID: 34791403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
    Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):350-353. PubMed ID: 37061836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.
    Kawashiri SY; Kawakami A; Sakamoto N; Ishimatsu Y; Eguchi K
    Rheumatol Int; 2012 Dec; 32(12):4023-6. PubMed ID: 20480164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
    Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
    Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review.
    Picchianti Diamanti A; Markovic M; Argento G; Giovagnoli S; Ricci A; Laganà B; D'Amelio R
    Ther Adv Respir Dis; 2017 Jan; 11(1):64-72. PubMed ID: 27733490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report.
    Mori Y; Izumiyama T; Mori N; Aizawa T
    Tohoku J Exp Med; 2021 May; 254(1):57-61. PubMed ID: 34053968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.
    Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T
    Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
    Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-positive lung adenocarcinoma in a patient with rheumatoid arthritis with long-term treatment for organizing pneumonia: A case report.
    Horie K; Asakura T; Masuzawa K; Terai H; Nakayama S; Suzuki Y
    Medicine (Baltimore); 2022 Dec; 101(49):e32159. PubMed ID: 36626420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis Complicated with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Interstitial Pneumonia.
    Matsumoto H; Sato S; Fujita Y; Yashiro-Furuya M; Matsuoka N; Asano T; Kobayashi H; Watanabe H; Migita K
    Intern Med; 2019 Mar; 58(5):737-742. PubMed ID: 30333415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
    Ota M; Iwasaki Y; Harada H; Sasaki O; Nagafuchi Y; Nakachi S; Sumitomo S; Shoda H; Tohma S; Fujio K; Yamamoto K
    Mod Rheumatol; 2017 Jan; 27(1):22-28. PubMed ID: 27142966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis associated interstitial lung disease: a review.
    Assayag D; Lee JS; King TE
    Medicina (B Aires); 2014; 74(2):158-65. PubMed ID: 24736263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review.
    Balbir-Gurman A; Guralnik L; Yigla M; Braun-Moscovici Y; Hardak E
    Autoimmun Rev; 2018 Feb; 17(2):87-93. PubMed ID: 29196242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.
    Chen J; Shi Y; Wang X; Huang H; Ascherman D
    Clin Dev Immunol; 2013; 2013():406927. PubMed ID: 23983768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
    Nakashita T; Ando K; Kaneko N; Takahashi K; Motojima S
    BMJ Open; 2014 Aug; 4(8):e005615. PubMed ID: 25125479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
    Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
    Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.